Valsartan CAS 137862-53-4 Assay 98.0~102.0% API
Ubonelelo loMvelisi iValsartan kunye nabaPhakathi abaNxulumeneyo:
Valsartan CAS: 137862-53-4
L-Valine Methyl Ester Hydrochloride (H-Val-OMe·HCl) CAS: 6306-52-1
Igama leMchiza | Valsartan |
Izithethantonye | N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine |
Inombolo yeCAS | 137862-53-4 |
Inombolo yeCAT | RF-API32 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C24H29N5O3 |
Ubunzima beMolekyuli | 435.52 |
Indawo yokunyibilika | 116.0 ~ 117.0℃ |
Uzinzo | Hygroscopic |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe okanye oMhlophe;Ayinavumba, iHygroscopic |
Ukuchongwa | I-spectrum ye-IR yesampuli ihambelana ne-spectrum yomgangatho wereferensi |
Ukuchongwa | Ixesha lokugcinwa kwencopho enkulu kwichromatogram yolungiselelo lovavanyo luhambelana nelo lolungiselelo olusemgangathweni, njengoko lufunyenwe kwi-Assay. |
Ukunyibilika | I-Soluble kwi-Methanol kunye ne-Ethanol, iNyibilika kancinane kwi-Ethylacetate, iNyibilika kancinane kwiDichloromethane, i-Soluble in Water |
Ukufuma (KF) | ≤1.00% |
I-Absorbance (420mm) | ≤0.02% (λ=420nm, C=0.05g/ml, L=1cm) |
Intsalela kwi-Ignition | ≤0.10% |
Iintsimbi ezinzima | ≤10ppm |
D-Valsartan | ≤1.00% (HPLC) |
Izinto eziyeleleneyo (HPLC) | |
I-Butyryl-Valsartan | ≤0.20% |
I-Benzyl-Valsartan | ≤0.10% |
Ukungahlambuluki okungaziwayo okungatshatanga | ≤0.10% |
Ukungcola ngokupheleleyo | ≤0.30% (Ngaphandle kwe-D-Valsartan) |
Intsalela yezinyibilikisi (GC) | |
IMethanol | ≤3000ppm |
I-Ethyl Acetate | ≤5000ppm |
N, N-Dimethylformamide | ≤880ppm |
Toluene | ≤890ppm |
Ubunyulu / Indlela yokuHlalutya | >99.0% (i-HPLC ibalwa ngesiseko se-anhydrous, i-solvent-free basis) |
Umgangatho woVavanyo | I-United States Pharmacopoeia (USP) |
Ukusetyenziswa | I-Active Pharmaceutical ingredient (API) |
I-Valsartan (CAS: 137862-53-4) Ukuhamba kweNkqubo yeMveliso
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi weValsartan (CAS: 137862-53-4) kunye nomgangatho ophezulu.I-Valsartan yi-nonpeptide angiotensin II AT1 receptor antagonist, i-Antihypertensive, inamandla oxinzelelo lwegazi kunye nophando lwentliziyo.
Iziphumo ze-antihypertensive ze-Valsartan zomelele kunezo ze-enalapril kwaye ifanelekile ukunyanga uxinzelelo lwegazi oluphezulu, oluphakathi ukuya koluphakathi lwe-hypertension, kwaye ngakumbi uxinzelelo lwegazi lwesibini olubangelwa kumonakalo wezintso.Inokunciphisa kakhulu i-proteinuria kwizigulane ezinesifo seswekile okanye imisebenzi eqhelekileyo yesibindi, kwaye inokukhuthaza i-uric acid kunye ne-urinary sodium ukukhusela intso.I-Valsartan ikwafanelekile ekunciphiseni ukusweleka kwentliziyo kwizigulana ezisengozini enkulu (ukusilela kwe-ventricular yasekhohlo okanye ukungasebenzi kakuhle) emva kokuhlaselwa sisifo sentliziyo.